Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial
Karina V Bunting, A. John Camm(St George's, University of London), Mary Stanbury(West Midlands Police), John Townend(NIHR Surgical Reconstruction and Microbiology Research Centre), Richard P. Steeds(University Hospitals Birmingham NHS Foundation Trust), Khalil Saadeh(University Hospitals Birmingham NHS Foundation Trust), Simrat Gill(University Hospitals Birmingham NHS Foundation Trust), Dipak Kotecha(University Hospitals Birmingham NHS Foundation Trust), Sandra Haynes(West Midlands Police)
Cited by 4
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
|The Lancet|2000|2k
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
|New England Journal of Medicine|1995|1.8k